Compare Wegovy vs Mounjaro: Private Access Options
Key Differences Between Wegovy and Mounjaro UK Private Prescriptions
The fundamental difference between Wegovy and Mounjaro lies in their active ingredients and mechanisms of action. Wegovy contains semaglutide, which targets GLP-1 receptors exclusively, while Mounjaro contains tirzepatide, targeting both GIP and GLP-1 receptors simultaneously. This dual-action approach makes Mounjaro unique among weight management medications currently available in the UK. Both are prescription-only medicines that require clinical assessment before prescribing. When accessing these treatments privately through EverydayMeds, you can avoid the typical NHS pathway which requires GP referral to specialist weight management services, often involving waiting periods of six months or more.
Private prescription access through our GPhC-registered pharmacy #9012878 enables you to compare both options with your prescriber during the clinical review process. The difference between Wegovy and Mounjaro UK availability means both medications can be prescribed following your online assessment, with your clinical team determining suitability based on your individual circumstances. This private route provides identical medications to those prescribed through NHS services, manufactured by the same pharmaceutical companies to identical standards, but without the associated delays and referral requirements.
Wegovy vs Mounjaro UK Pricing: Private Prescription Costs
Understanding the difference between Wegovy and Mounjaro UK pricing helps inform your treatment decision. Wegovy follows a structured dose escalation schedule, with 0.25mg starter doses at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the maintenance dose of 2.4mg (£209.99). These prices reflect the final cost after applying discount codes FIRST40 for new customers or DOSE25 for returning patients at checkout. Mounjaro pricing follows a similar escalation pattern but with different dose strengths reflecting its distinct formulation. Both medications require gradual dose increases over 16-20 weeks to reach maintenance levels, making the total treatment cost comparable between options.
Our bundle options provide convenient multi-month supplies for both medications, such as the Intro Trio (0.25mg, 0.5mg, 1mg Wegovy) at £299.99 or consistency bundles for maintenance dosing. The difference between Wegovy and Mounjaro UK cost structures reflects their different dose escalation schedules, but both represent significant savings compared to many European private healthcare systems. Payment is straightforward with no subscription commitments, allowing you to order individual pens or bundles based on your treatment progression and budget preferences.
Clinical Evidence: Comparing Wegovy and Mounjaro Effectiveness
The difference between Wegovy and Mounjaro UK clinical evidence stems from their distinct trial programmes and mechanisms. In the STEP clinical trials, patients taking Wegovy alongside diet and exercise achieved an average weight loss of approximately 15% at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme included over 4,500 participants across multiple studies, demonstrating consistent weight management benefits when combined with lifestyle modifications.
Mounjaro's clinical evidence comes from the SURMOUNT trial series, where tirzepatide demonstrated significant weight management benefits through its dual receptor approach. However, direct comparison between these medications isn't straightforward as the trials used different designs, patient populations, and endpoints. Both medications have received MHRA approval for weight management in adults with BMI ≥30, or BMI ≥27 with weight-related comorbidities, indicating both meet stringent efficacy and safety standards for UK use.
How Wegovy Works: Understanding the GLP-1 Mechanism
Wegovy's active ingredient, semaglutide, functions as a GLP-1 receptor agonist, mimicking a natural hormone that regulates appetite and blood sugar levels. When you inject Wegovy weekly, it activates GLP-1 receptors in your brain's appetite centres, promoting feelings of fullness and reducing food cravings. This mechanism may help you feel satisfied with smaller portions and experience less frequent hunger between meals. The medication also slows gastric emptying, meaning food remains in your stomach longer, contributing to prolonged satiety. These combined effects support weight management when used alongside a reduced-calorie diet and increased physical activity, as the medication doesn't work independently of lifestyle modifications.
Private Prescription Process: Accessing Wegovy or Mounjaro
The difference between Wegovy and Mounjaro UK access through private prescription lies in the streamlined assessment process available through EverydayMeds. Your journey begins with a 3-minute online clinical assessment covering your medical history, current medications, weight management goals, and any relevant health conditions. This assessment is then reviewed by our qualified prescribers within 24-72 hours (or 24 hours with express service), who determine which medication might be most suitable for your circumstances. Once approved, your medication is dispatched via next-day delivery using cold-chain transport to maintain the required 2-8°C temperature throughout transit. This entire process bypasses traditional GP consultations and specialist referrals, providing faster access to the same medications available through NHS pathways.
Storage and Practical Considerations: Wegovy vs Mounjaro
A practical difference between Wegovy and Mounjaro UK lies in their storage requirements and temperature stability. Wegovy can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, while Mounjaro maintains stability for 21 days at room temperature. This makes Wegovy more suitable for travel or situations where refrigeration isn't consistently available. Both medications use pre-filled pens designed for weekly injection, with Wegovy using Novo Nordisk's FlexTouch pen technology and Mounjaro using Eli Lilly's KwikPen system. The dose escalation schedules differ slightly between medications, with Wegovy following a 16-week escalation to 2.4mg maintenance, while Mounjaro has its own distinct progression schedule. Both require injection into the thigh, abdomen, or upper arm, rotating injection sites weekly to prevent lipodystrophy.
Choosing Between Wegovy and Mounjaro: Private Prescription Advantages
The difference between Wegovy and Mounjaro UK selection often depends on individual factors best assessed during private clinical consultation. Some patients may respond better to single-target GLP-1 therapy (Wegovy), while others might benefit from dual-receptor activation (Mounjaro). Your prescriber considers factors including previous medication responses, existing health conditions, lifestyle requirements, and personal preferences regarding injection frequency and storage needs. Private prescription access allows for more personalised discussion about these factors without the time constraints often present in NHS consultations.
The private route also enables more flexible medication switching if your initial choice proves less suitable than anticipated. Through EverydayMeds, you can maintain ongoing communication with prescribers about your treatment response, side effects, or changing circumstances that might influence your medication choice. This level of personalised care, combined with convenient home delivery and no waiting lists, represents the key advantage of choosing private prescription access for weight management medications in the UK.
Complete Your Assessment: Wegovy or Mounjaro Available Today
Both Wegovy and Mounjaro are available through EverydayMeds' private prescription service, with your clinical team helping determine which option aligns with your weight management goals. Use discount code FIRST40 for new customers or DOSE25 for returning patients to access our competitive pricing, with Wegovy starting from £79.99 and comprehensive bundle options available for extended treatment. Your online assessment takes just minutes to complete, with prescriber review and next-day delivery ensuring rapid access to either medication. Our GPhC-registered pharmacy #9012878 maintains the highest standards for medication storage, handling, and delivery, providing the same quality medications available through NHS services but without the associated delays. Remember that both medications work most effectively alongside a reduced-calorie diet and increased physical activity, representing one component of a comprehensive weight management approach.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
